NAT2 sequence polymorphisms and acetylation profiles in Indians

Pharmacogenomics

Volumn 14, Issue 3, 2013, Pages 289-303

  Khan, Naazneen ^a   Pande, Veena ^b   Das, Aparup ^a  

^a Division of Genomics and Bioinformatics   (India)

^b KUMAUN UNIVERSITY   (India)

Author keywords

acetylation phenotypes; drug metabolization; India; N acetyltransferase 2; NAT2; pharmacogenetic

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ASPARAGINE; LYSINE;

ACETYLATOR PHENOTYPE; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG ACETYLATION; EATING HABIT; GENE FREQUENCY; HUMAN; INDIA; INDIAN; NAT2 GENE; NEIGHBOR JOINING METHOD; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VEGETARIAN;

ACETYLATION; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; EVOLUTION, MOLECULAR; FOOD HABITS; HUMANS; INDIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873663885     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.2     Document Type: Article

References (75)

1. Luca F, Bubba G, Basile M et al. Multiple advantageous amino acid variants in the NAT2 gene in human populations. PLo S One 3(9), e3136 (2008).
2. Windmill KF, Gaedigk A, Hall PD et al. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol. Sci. 54(1), 19-29 (2000).
3. Sabbagh A, Darlu P, Crouau-Roy B et al. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLo S One 6(4), e18507 (2011).
4. Boukouvala S, Sim E. Structural analysis of the genes for human arylamine N-acetyltransferases and characterization of alternative transcripts. Basic Clin. Pharmacol. Toxicol. 96(5), 343-351 (2005).
5. Hein DW. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25(11) 1649-1658 (2006).
6. Kerb R, Fux R, Mörike K et al. Pharmacogenetics of antimalarial drugs: effect on metabolism and transport. Lancet Infect. Dis. 9(12), 760-774 (2009).
7. Garcia-Martin E. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr. Drug Metab. 9 (6), 487-497 (2008).
8. Hein DW, Doll MA. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics 13(1), 31-41 (2012).
9. Magalon H, Patin E, Austerlitz F et al. Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia. Eur. J. Hum. Genet. 16(2), 243-251(2008).
10. Taja-Chayeb L, Agundez JA, Miguez-Munoz C et al. Arylamine N-acetyltransferase 2 genotypes in a Mexican population. Genet. Mol. Res. 11(2), 1082-1092 (2012).
11. Fuselli S, Gilman RH, Chanock SJ et al. Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J. 7(2), 1-9 (2007).
12. Teixeira RL, Silva FP Jr, Silveira AR et al. Sequence analysis of NAT2 gene in Brazilians: identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure. Mutat. Res. 683 (1-2), 43-49 (2010).
13. Butcher NJ, Boukouvala S, Sim E et al. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J. 2, 30-42 (2002).
14. Chaudhary S, Behari M, Dihana M et al. Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians. Pharmacogenet. Genomics, 15(10), 731-735 (2005).
15. Luisa R, Carlos G, Alexandre M et al. N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease. Pharmacogenetics, 9(1), 9-16 (1999).
16. David M, Donald PP, Heine IS et al. NAT2 slow acetylator function as a risk indicator for age related cataract formation. Pharmacogenetics 13(5), 285-289 (2003).
17. Saiz PA, Garcia-Portilla MP, Arango C et al. N-acetyltransferase-2 polymorphisms and schizophrenia. Eur. Psychiatry 21(5), 333-337 (2006).
18. Talbot J, Magno LAV, Santana CV et al. Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations. BMC Genetics 11, 87 (2010).
19. Eisenstein M. Diversity: of beans and genes. Nature 468(7327), S13-S15 (2010).
20. Sabbagh A, Langaney A, Darlu P et al. Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genetics 9, 21 (2008).
21. Patin E, Barreiro LB, Sabeti PC et al. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am. J. Hum. Genet. 78(3), 423-436 (2006).
22. Bekaert S, Storozhenko S, Mehrshahi P et al. Folate biofortification in food plants. Trends Plant Sci. 13(1), 1360-1385 (2007).
23. Badr A, Muller K, Schafer-Pregl R et al. On the origin and domestication history of barley (Hordeum vulgare). Mol. Biol. Evol. 17(4), 499-510 (2000).
24. Zeder MA. Evolutionary biology and the emergence of agriculture: the value of co-opted models of evolution in the study of culture change. In: Macroevolution in Human Prehistory. Prentiss AM (Eds), Springer-Verlag, NY, USA, 157-210 (2009).
25. Jayanthi V. Vegetarianism in India. Proceedings of the ISPD. The IXth Congress of the ISPD - Montréal, Canada. Peritoneal Dialysis International 21(Suppl. 3), 26-29 (2001).
26. Mitra A, Basu B, Mukherjee S. Significance of different dietary habits in sections of Indian diabetics. J. Hum. Ecol. 26(2), 89-98 (2009).
27. Chakravarti A. Regional preference for food: some aspects of food habit patterns in India. Canadian Geographer 18(4), 395-410 (1974).
28. Pande JN, Pande A, Singh SPN. Acetylator status, drug metabolism and disease. Natl Med. J. India 16(1), 24-26 (2003).
29. Anitha A, Banerjee M. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of south India. Int. J. Mol. Med. 11(1), 125-131 (2003).
30. Thanseem I, Thangaraj K, Chaubey G et al. Genetic affinities among the lower castes and tribal groups of India: inference from Y chromosome and mitochondrial DNA. BMC Genetics 7, 42 (2006).
31. Cann RL. Genetic clues to dispersal of human population: retracing the past from the present. Science 291(5509), 1742-1748 (2001).
32. Suarez-Kurtz G, Vargens DD, Sortica VA et al. Accuracy of NAT2 SNP genotyping panels to infer acetylator phenotypes in African, Asian, Amerindian and admixed population. Pharmacogenomics 13(8), 851-854 (2012).
33. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68(4), 978-989 (2001).
34. Kuznetsov IB, Mc Duffifie M, Moslehi R. A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype. Bioinformatics 25(9), 1185-1186 (2009).
35. Felsenstein J. Phylip-phylogeny inference package. Cladistics 5, 164-166 (1989).
36. Matimba A, del-Favero J, van Broeckhoven C et al. Novel variants of major drug metabolizing enzyme genes in diverse African populations and their predicted functional effects. Hum. Genomics 3(2), 169-190 (2009).
37. Loktionov A, Moore W, Spencer SP et al. Differences in N-acetylation genotypes between Caucasians and black South Africans: implications for cancer prevention. Cancer Detect. Prev. 26(1), 15-22 (2002).
38. Patin E, Harmant C, Kidd KK et al. Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene. Hum. Mutat. 27(7), 720 (2006).
39. Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr. Drug Metab. 9(6), 520-531 (2008).
40. Dandara C, Masimirembwa CM, Magimba A et al. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A. Pharmacogenetics 13(1), 55-58 (2003).
41. Mrozikiewicz PM, Cascorbi I, Brockmöller J et al. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population. Clin. Pharmacol. Ther. 59(4), 376-382 (1996).
42. Rabstein S, Unfried K, Ranft U et al. Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population. Cancer Epidemiol. Biomarkers Prev. 15(1), 138-141 (2006).
43. Martinez C, Agundez JA, Olivera M et al. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 5(4), 207-214 (1995).
44. Jorge-Nebert LF, Eichelbaum M, Griese EU et al. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Pharmacogenetics 12(1), 39-48 (2002).
45. Tamura K, Peterson D, Peterson N et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol. Biol. Evol. 24, 1596-1599 (2011).
46. Hamblin MT, Thompson EE, Di Rienzo A. Complex signatures of natural selection at the duffy blood group locus. Am. J. Hum. Genet. 70(2), 369-383 (2002).
47. Saunders MA, Hammer MF, Nachman MW. Nucleotide variability at G6pd and the signature of malarial selection in humans. Genetics 162, 1849-1861 (2002).
48. Morrell PL, Clegg MT. Genetic evidence for a second domestication of barley (Hordeum vulgare) east of the Fertile Crescent. Proc. Natl Acad. Sci. USA 104(9), 3289-3294 (2007).
49. Teixeira RL, Silva Jr FP, Silveira AR et al. Sequence analysis of NAT2 gene in Brazilians: identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure. Mutat. Res. 683(1-2), 43-49 (2010).
50. Narang A, Jha P, Rawat V et al. Recent admixture in an Indian population of African ancestry. Am. J. Hum. Genet. 89(1), 111-120 (2011).
51. Winters C. Origin of the Niger-Congo speakers. Webmed Central Genet. 3(3), WMC003149 (2012).
52. Giolo SR, Soler JMP, Greenway SC et al. Brazilian urban population genetic structure reveals a high degree of admixture. Eur. J. Hum. Genet. 20(1), 111-116 (2012).
53. Fuselli S, Tarazona-Santos E, Dupanloup E et al. Mitochondrial DNA diversity in South America And the genetic history of Andean highlanders. Mol. Biol. Evol. 20(10), 1682-1691 (2003).
54. Al-Moundhri MS, Al-Kindi M, Al-Nabhani M et al. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World J. Gastroenterol. 13(19), 2697-2702 (2007).
55. Petraglia MD. Hominin responses to Pleistocene environmental change in Arabia and south Asia. Geological Society 247, 305-319 (2005).
56. Xing J, Watkins WS, Hu Y et al. Genetic diversity in India and the inference of Eurasian population expansion. Genome Biol. 11(11), R113 (2010).
57. Reddy BM, Langstieh BT, Kumar V et al. Austro-Asiatic tribes of northeast India provide hitherto missing genetic link between south and southeast Asia. PLo S One 2(11), e1141 (2007).
58. Stoneking M, Delfin F. The human genetic history of east Asia: weaving a complex tapestry. Curr. Biol. 20(4), R188-R193 (2010).
59. Luca F, Perry GH, Di-Rienzo A. Evolutionary adaptations to dietary changes. Annu. Rev. Nutr. 30, 291-314 (2010).
60. Cordain L, Eaton SB, Sebastian A et al. Origins and evolution of the western diet: health implications for the 21st century. Am. J. Clin. Nutr. 81(2), 341-354 (2005).
61. Gignoux CR, Henn BM, Mountain JL. Rapid, global demographic expansions after the origins of agriculture. Proc. Natl Acad. Sci. USA 108 (15), 6044-6049 (2011).
62. Bamshad M, Kivisild T, Watkins WS et al. Genetic evidence on the origins of Indian caste populations. Genome Res. 11(6), 994-1004 (2001).
63. Brown TA, Jones MK, Powell W, Allaby RG. The complex origins of domesticated crops in the Fertile Crescent. Trends Ecol. Evol. 24(2), 103-109 (2009).
64. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123(3), 585-595 (1989).
65. Sinha R, Lakra V. Wild tribal food plants of Orissa. Indian J. Traditional Knowledge 4(3), 246-252 (2005).
66. Bamshad M. Kivisild T, Watkins WS et al. Genetic evidence on the origins of Indian caste populations. Genome Res. 11(6), 994-1004 (2001).
67. Cordaux R, Saha N, Bentley GR et al. Mitochondrial DNA analysis reveals diverse histories of tribal populations from India. Eur. J. Hum. Genet. 11(3), 253-264 (2003).
68. Yuliwulandari R, Sachrowardi Q, Nishida N et al. Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature. J. Hum. Genet. 53(3), 201-209 (2008).
69. Cavaco I, Asimus S, Peyrard-Janvid M et al. The Vietnamese Khin population harbors particular N-acetyltransferase 2 allele frequencies. Clin. Chem. 53(11), 1977-1979 (2007).
70. Segurel L, Lafosse S, Heyer E et al. Frequency of the AGT Pro11Leu polymorphism in humans: does diet matter? Ann. Hum. Genet. 74(1), 57-64 (2010).
71. Mehra NK. Defining genetic architecture of the populations in the Indian subcontinent: impact of human leukocyte antigen diversity studies. Indian J. Hum. Genet. 16(3), 105-107 (2010).
72. Wooding SP, Watkins WS, Bamshad MJ et al. DNA sequence variation in a 3.7 kb noncoding sequence 5́ of the CYP1A2 gene: implications for human population history and natural selection. Am. J. Hum. Genet. 71(3), 528-542 (2002).
73. Jha N. Permian palynology from India and Africa - a phytogeographical paradigm. J. Paleontol. Soc. India 51(1), 43-55 (2006).
74. Vishwanathan H, Deepa E, Cordaux R et al. Genetic structure and affinities among tribal populations of southern India: a study of 24 autosomal DNA markers. Ann. Hum. Genet. 68, 128-138 (2004).
75. Majumder PP. People of India: biological diversity and affinities. Evol. Anthropol. 6(3), 100-110 (1998).